secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001213900-25-022279
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex prices $12.5M private placement at $1.08/share to fund OSA trial
-------------------------------------------------------------------------

- Gross proceeds $12.5M from 11.57M shares at $1.08 plus Series A warrants at $2.16.
- Net proceeds ~$11.3M after placement agent fees and expenses.
- Funds IHL-42X Phase 2/3 OSA study completion and Phase 3 expansion.
- Proceeds also repay outstanding convertible debentures and for working capital.
- Transaction closed March 10, 2025; R.F. Lafferty as sole placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/0001213900-25-022279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/ea0233697-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-022279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer